e-Therapeutics

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Ingredients

e-therapeutics launches anti-viral drug discovery initiative for COVID-19

UK-based e-therapeutics discusses the moral responsibility of business and reaches out for aid with a network-driven drug discovery platform to help the current pandemic
Research & Development

Could machine learning present a paradigm shift in drug discovery?

Angharad Baldwin catches up with Dr Raymond Barlow, CEO at e-therapeutics, about what network-driven drug discovery can offer the pharmaceutical industry in its pursuit of new medicines
Research & Development

Collaboration to enhance and extend AI technology capabilities

e-Therapeutics, a company pioneering the use of network-driven drug discovery (NDD) to create new and better drugs, announced agreements with Intellegens and Biorelate to develop artificial intelligence (AI) technology capabilities

Raymond Barlow takes up role as CEO of e-Therapeutics

Appointment of Amgen Executive Director as Chief Executive

e-Therapeutics plc, the drug discovery company, announces that it has appointed Dr. Raymond Barlow as Chief Executive Officer.
Research & Development

PM David Cameron opens e-Therapeutics’ drug discovery centre

Network Pharmacology Centre will search for novel treatments for cancer and CNS diseases
Subscribe now